134 related articles for article (PubMed ID: 35421765)
1. Binding of the anticancer Ti(IV) complex phenolaTi to serum proteins: Thermodynamic and kinetic aspects.
Shpilt Z; Tshuva EY
J Inorg Biochem; 2022 Jul; 232():111817. PubMed ID: 35421765
[TBL] [Abstract][Full Text] [Related]
2. Titanium complexes affect
Hayet S; Ghrayeb M; Azulay DN; Shpilt Z; Tshuva EY; Chai L
RSC Med Chem; 2023 May; 14(5):983-991. PubMed ID: 37252093
[TBL] [Abstract][Full Text] [Related]
3. Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride.
Guo M; Sun H; McArdle HJ; Gambling L; Sadler PJ
Biochemistry; 2000 Aug; 39(33):10023-33. PubMed ID: 10955990
[TBL] [Abstract][Full Text] [Related]
4. Phenolato Ti(IV) hexacoordinate complexes for anticancer chemotherapy: enhancement of solubility, hydrolytic stability, and cytotoxicity.
Taha M; Tshuva EY
Dalton Trans; 2023 Jun; 52(22):7664-7672. PubMed ID: 37199994
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
6. Hydrolytic metal with a hydrophobic periphery: titanium(IV) complexes of naphthalene-2,3-diolate and interactions with serum albumin.
Tinoco AD; Eames EV; Incarvito CD; Valentine AM
Inorg Chem; 2008 Sep; 47(18):8380-90. PubMed ID: 18710217
[TBL] [Abstract][Full Text] [Related]
7. Reconsideration of serum Ti(IV) transport: albumin and transferrin trafficking of Ti(IV) and its complexes.
Tinoco AD; Eames EV; Valentine AM
J Am Chem Soc; 2008 Feb; 130(7):2262-70. PubMed ID: 18225897
[TBL] [Abstract][Full Text] [Related]
8. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
Peri D; Meker S; Manna CM; Tshuva EY
Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells.
Hernández R; Lamboy J; Gao LM; Matta J; Román FR; Meléndez E
J Biol Inorg Chem; 2008 Jun; 13(5):685-92. PubMed ID: 18288505
[TBL] [Abstract][Full Text] [Related]
10. Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents.
Meker S; Braitbard O; Hall MD; Hochman J; Tshuva EY
Chemistry; 2016 Jul; 22(29):9986-95. PubMed ID: 27320784
[TBL] [Abstract][Full Text] [Related]
11. Applying the Fe(III) binding property of a chemical transferrin mimetic to Ti(IV) anticancer drug design.
Parks TB; Cruz YM; Tinoco AD
Inorg Chem; 2014 Feb; 53(3):1743-9. PubMed ID: 24422475
[TBL] [Abstract][Full Text] [Related]
12. An anticancer Ti(IV) complex increases mitochondrial reactive oxygen species levels in relation with hypoxia and endoplasmic-reticulum stress: A distinct non DNA-related mechanism.
Shpilt Z; Melamed-Book N; Tshuva EY
J Inorg Biochem; 2023 Jun; 243():112197. PubMed ID: 36963201
[TBL] [Abstract][Full Text] [Related]
13. From medium to endoplasmic reticulum: Tracing anticancer phenolato titanium(IV) complex by
Nahari G; Hoffman RE; Tshuva EY
J Inorg Biochem; 2021 Aug; 221():111492. PubMed ID: 34051630
[TBL] [Abstract][Full Text] [Related]
14. Ti(IV) binds to human serum transferrin more tightly than does Fe(III).
Tinoco AD; Valentine AM
J Am Chem Soc; 2005 Aug; 127(32):11218-9. PubMed ID: 16089431
[TBL] [Abstract][Full Text] [Related]
15. Calorimetric, spectroscopic, and model studies provide insight into the transport of Ti(IV) by human serum transferrin.
Tinoco AD; Incarvito CD; Valentine AM
J Am Chem Soc; 2007 Mar; 129(11):3444-54. PubMed ID: 17315875
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of asymmetrical diaminobis(alkoxo)-bisphenol compounds and their C
Nahari G; Tshuva EY
Dalton Trans; 2021 May; 50(19):6423-6426. PubMed ID: 33949509
[TBL] [Abstract][Full Text] [Related]
17. Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride.
Guo M; Guo Z; Sadler PJ
J Biol Inorg Chem; 2001 Sep; 6(7):698-707. PubMed ID: 11681703
[TBL] [Abstract][Full Text] [Related]
18. Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.
Loza-Rosas SA; Vázquez-Salgado AM; Rivero KI; Negrón LJ; Delgado Y; Benjamín-Rivera JA; Vázquez-Maldonado AL; Parks TB; Munet-Colón C; Tinoco AD
Inorg Chem; 2017 Jul; 56(14):7788-7802. PubMed ID: 28644630
[TBL] [Abstract][Full Text] [Related]
19. Effective Oral Administration of an Antitumorigenic Nanoformulated Titanium Complex.
Nahari G; Braitbard O; Larush L; Hochman J; Tshuva EY
ChemMedChem; 2021 Jan; 16(1):108-112. PubMed ID: 32657024
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical formulation affects titanocene transferrin interactions.
Buettner KM; Snoeberger RC; Batista VS; Valentine AM
Dalton Trans; 2011 Oct; 40(37):9580-8. PubMed ID: 21847473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
